Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
166.87
-5.42 (-3.15%)
At close: Nov 16, 2026, 4:00 PM EST
167.80
+0.93 (0.56%)
After-hours: Nov 16, 2026, 7:57 PM EST
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $36.09 billion as of November 16, 2026. It is the 684th most valuable company in the world and the 315th biggest in the United States. Its market cap has increased by 175.57% in one year.
Market Cap
36.09B
Enterprise Value
33.65B
1-Year Change
175.57%
Global Rank
Country Rank
#315 United States
Category
ChartMarket Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $36.09B, an increase of 2,094.78%. That is a compound annual growth rate of 57.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 36.09B | 134.37% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 60.62B |
| BeOne Medicines AG | 47.58B |
| Royalty Pharma | 39.76B |
| Genmab | 32.22B |
| Roivant Sciences | 28.64B |
| Insmed | 26.58B |
| Incyte | 24.66B |
| Alnylam Pharmaceuticals | 22.11B |